Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/70318/000119312511046322/d10k.htm
Exhibit 99.1
Tenet Reports Fourth Quarter 2010 Results
Earnings of $0.14 per diluted share in Q410, compared to $0.04 in Q409
Company Confirms 2011 Outlook
Fourth Quarter 2010 Key Metrics
| Net income attributable to common shareholders of $74 million in Q410, compared to $21 million in Q409, an increase of 252 percent |
| Adjusted EBITDA of $281 million in Q410, compared to $218 million in Q409, an increase of 28.9 percent |
| Adjusted EBITDA margin of 12.2 percent in Q410, compared to 9.6 percent in Q409, an increase of 260 basis points |
2010 Key Metrics
| Net income attributable to common shareholders of $1.119 billion in 2010, compared to $181 million in 2009 (2010 net income included the recognition of $1.043 billion of tax benefits) |
| Earnings of $2.04 per diluted share in 2010, compared to $0.37 per diluted share in 2009 |
| Adjusted EBITDA of $1.050 billion in 2010, compared to $982 million in 2009, an increase of 6.9 percent |
| Adjusted EBITDA margin of 11.4 percent in 2010, compared to 10.9 percent in 2009, an increase of 50 basis points |
Subsequent Events in Q111
| California Provider Fee Program received CMS final approval on January 18, 2011 |
| $64 million will be recorded in net revenue in Q111 |
DALLAS Feb. 25, 2011 Tenet Healthcare Corporation (NYSE:THC) today reported adjusted EBITDA of $281 million for the fourth quarter ended December 31, 2010, an increase of $63 million, or 28.9 percent, compared to $218 million for the fourth quarter of 2009. Net income attributable to common shareholders for the fourth quarter of 2010 was $74 million, or $0.14 per diluted share, compared to $21 million, or $0.04 per diluted share, for the fourth quarter of 2009.
Our volume trends showed significant improvement in November and December compared to the first ten months of the year. Those strengthening trends have continued into January and February 2011. In the fourth quarter of 2010 we achieved a 3.2 percent increase in paying outpatient visits compared to 2009s fourth quarter. Strong pricing growth and continued excellent cost performance also contributed to a solid quarter. Our full year 2010 adjusted EBITDA of $1.05 billion is the highest in seven years, and the seventh consecutive year of EBITDA growth. Our adjusted EBITDA margin of 12.2 percent in the fourth quarter is the highest fourth quarter margin weve reported in seven years, and our full year 2010 margin of 11.4 percent is the highest in seven years, said Trevor Fetter, president and chief executive officer. We are reconfirming our 2011 outlook for adjusted EBITDA in a range of $1.150 billion to $1.250 billion and we are introducing our 2011 outlook for net cash provided by operating activities in the range of $570 million to $740 million.
Discussion of Results (Percentage changes compare Q410 to Q409, unless otherwise noted.)
Admissions and paying admissions declined by 2.0 percent and 2.2 percent, respectively. These declines were smaller than the respective declines of 3.5 percent and 3.9 percent in the sequential third quarter of 2010. Outpatient visits and paying outpatient visits increased by 2.9 and 3.2 percent, respectively compared to the fourth quarter of 2009. Adjusted admissions increased by 0.4 percent compared to the fourth quarter of 2009.
Net operating revenues were $2.301 billion, an increase of $40 million, or 1.8 percent, compared to net operating revenues of $2.261 billion in the fourth quarter of 2009. Net patient revenues per adjusted patient day increased by 2.4 percent.
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Tenet Healthcare Corp.
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/70318/000119312511046322/d10k.htm
Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.
ContinueRead positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.
ContinueRemove data columns and navigations in order to see much more filing content and tables in one view
ContinueRead both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
ContinueExport Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis
ContinueGet one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREEOur Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
ContinueOur Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
ContinueSee how over 70
Growth, Profitability and Financial Ratios perform over 10 Years